Eli Lilly’s blockbuster antidepressant Cymbalta can now also be marketed as a treatment for chronic musculoskeletal pain, such as osteoarthritis and lower back pain, following FDA approval yesterday.
Continue reading Eli Lilly Antidepressant Cymbalta Approved for Chronic Pain
Eli Lilly Antidepressant Cymbalta Approved for Chronic Pain originally appeared on DailyFinance on Fri, 05 Nov 2010 11:50:00.
Filed Under: Company News, Health Care, Eli Lilly